Stobezki Robert, Titus Shiny, Halicka Dorota, Darzynkiewicz Zbigniew, Oktay Kutluk
Department of Obstetrics and Gynecology, Laboratory of Molecular Reproduction and Fertility Preservation, Yale University School of Medicine, 310 Cedar Street, FMB Room # 224, New Haven, CT, 06510, USA.
Department of Pathology and Brander Cancer Research Institute, New York Medical College, Valhalla, NY, 10595, USA.
Reprod Sci. 2020 Mar;27(3):940-953. doi: 10.1007/s43032-019-00098-1. Epub 2020 Jan 8.
Recent data suggest that paternal age can have major impact on reproductive outcomes, and with increased age, there is increased likelihood of chromosomal abnormalities in the sperm. Here, we studied DNA damage and repair as a function of male aging and assessed whether sphingosine-1-phosphate (S1P), a ceramide-induced death inhibitor, can prevent sperm aging by enhancing DNA double-strand breaks (DSB) repair. We observed a significant increase in DNA damage with age and this increase was associated with a decline in the expression of key DNA DSB repair genes in mouse sperm. The haploinsufficiency of BRCA1 male mice sperm showed significantly increased DNA damage and apoptosis, along with decreased chromatin integrity when compared to similar age wild type (WT) mice. Furthermore, haploinsufficiency of BRCA1 male mice had lower sperm count and smaller litter size when crossed with WT females. The resulting embryos had a higher probability of growth arrest and reduced implantation. S1P treatment decreased genotoxic-stress-induced DNA damage in sperm and enhanced the expressions of key DNA repair genes such as BRCA1. Co-treatment with an ATM inhibitor reversed the effects of S1P, implying that the impact of S1P on DNA repair is via the ATM-mediated pathway. Our findings indicate a key role for DNA damage repair mechanism in the maintenance of sperm integrity and suggest that S1P can improve DNA repair in sperm. Further translational studies are warranted to determine the clinical significance of these findings and whether S1P can delay male reproductive aging. There is mounting evidence that sperm quality declines with age, similar to that of the oocyte. However, the reasons behind this decline are poorly understood and there is no medical intervention to improve sperm quality. Our study suggests a strong role for DNA damage repair in maintenance of sperm quality, and for the first time, a potential pharmaceutical approach to prevent sperm aging.
近期数据表明,父亲年龄可对生殖结果产生重大影响,且随着年龄增长,精子中染色体异常的可能性增加。在此,我们研究了DNA损伤与修复作为男性衰老的一项功能,并评估了鞘氨醇-1-磷酸(S1P)(一种神经酰胺诱导的死亡抑制剂)是否可通过增强DNA双链断裂(DSB)修复来预防精子衰老。我们观察到,随着年龄增长,DNA损伤显著增加,且这种增加与小鼠精子中关键DNA DSB修复基因的表达下降有关。与同龄野生型(WT)小鼠相比,BRCA1雄性小鼠精子的单倍剂量不足表现出DNA损伤和凋亡显著增加,同时染色质完整性降低。此外,BRCA1雄性小鼠单倍剂量不足与WT雌性小鼠交配时,精子数量减少,窝仔数变小。所产生的胚胎生长停滞的可能性更高,着床减少。S1P处理可降低精子中基因毒性应激诱导的DNA损伤,并增强BRCA1等关键DNA修复基因的表达。与ATM抑制剂联合处理可逆转S1P的作用,这意味着S1P对DNA修复的影响是通过ATM介导的途径。我们的研究结果表明,DNA损伤修复机制在维持精子完整性方面起关键作用,并表明S1P可改善精子中的DNA修复。有必要进行进一步的转化研究,以确定这些发现的临床意义以及S1P是否可延缓男性生殖衰老。越来越多的证据表明,与卵母细胞类似,精子质量会随着年龄下降。然而,这种下降背后的原因尚不清楚,且尚无改善精子质量的医学干预措施。我们的研究表明,DNA损伤修复在维持精子质量方面发挥着重要作用,并且首次提出了一种预防精子衰老的潜在药物方法。